'I just keep thinking I have't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners

Fu-Meng Khaw; Stobbart, Lynne; Murtagh, Madeleine J.
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p1
Academic Journal
Background: Hepatitis C viral (HCV) infection is a significant public health problem. In the UK, an estimated 200,000 individuals have active HCV infection, most of whom are injecting drug users (IDUs). Many IDUs spend time within the prison system therefore screening for HCV infection in this setting is important. However, uptake of testing within prisons is very low. Methods: Qualitative interview study. 30 interviews with 25 male and 5 female prisoners with a history of injecting drug use. Results: Personal and institutional barriers to uptake of testing for HCV were identified. Personal barriers included: prisoners' fears and lack of knowledge about HCV, low motivation for testing, lack of awareness about the testing procedure, and concerns about confidentiality and stigma. Institutional barriers included: the prisons' applications procedure for testing, inadequate pre- and post-test discussion, lack of pro-active approaches to offering testing, and lack of continuity of care on discharge and transfer. Conclusion: This study highlights potential areas of development in the management of HCV in prisons. Further research is needed to evaluate care pathways for HCV in the prison setting and to develop and assess interventions to improve the uptake of testing for HCV by prisoners.


Related Articles

  • An audit of hepatitis C service provision in a representative sample of prisons in England. Humphreys, Clare; Railton, Cathie; O'Moore, Éamonn; Lombard, Martin; Newton, Autilia // Journal of Public Health;Mar2015, Vol. 37 Issue 1, p151 

    Background Prisons are an important setting to address prevention, testing and treatment of hepatitis C virus (HCV) and other blood-borne viruses. This audit examined current practice against national standards in a representative sample of prisons in England. Methods The audit tool was...

  • The Experience of Hepatitis C Screening among Prison Inmates with Drug Injection History. Kaffashian, Alireza; Nokhodian, Zari; Kassaian, Nazila; Babak, Anahita; Yaran, Majid; Shoaei, Parisa; Ataei, Behrooz; Adibi, Peyman // Journal of Isfahan Medical School;3/28/2011 Supplement, Vol. 28, p1 

    Background: Hepatitis C is a major worldwide problem with remarkable medical burden which is emerging mostly due to intravenuos drug abuse. The prevalence of hepatitis C infection is higher among prison inmates because of the high proportion of injecting drug users. So, the aim of this study was...

  • Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons. Tianhua He; Kan Li; Roberts, Mark S.; Spaulding, Anne C.; Ayer, Turgay; Grefenstette, John J.; Chhatwal, Jagpreet; He, Tianhua; Li, Kan // Annals of Internal Medicine;1/19/2016, Vol. 164 Issue 2, p84 

    Background: The prevalence of hepatitis C virus (HCV) in U.S. prisoners is high; however, HCV testing and treatment are rare. Infected inmates released back into society contribute to the spread of HCV in the general population. Routine hepatitis screening of inmates followed by new...

  • Screening for Hepatitis C Virus Infection: Recommendations from the U.S. Preventive Services Task Force.  // Annals of Internal Medicine;3/16/2004, Vol. 140 Issue 6, pI62 

    Recommends screening for Hepatitis C virus (HCV) infection by the United States Preventive Services Task Force (USPSTF). Ability to available tests to accurately identify people with HCV infection; Need for doctors and patients to be aware that screening for HCV infection to not improve patient...

  • A Framework for Management of Hepatitis C in Prisons. Spaulding, Anne C.; Weinbaum, Cindy M.; Lau, Daryl T.-Y.; Sterling, Richard; Seeff, Leonard B.; Margolis, Harold S.; Hoofnagle, Jay H. // Annals of Internal Medicine;5/16/2006, Vol. 144 Issue 10, p762 

    The prevalence of chronic hepatitis C virus (HCV) infection in prisons ranges from 12% to 31%. There are generally accepted-albeit still evolving-guidelines for identification and treatment of hepatitis C in the community. However, there is less agreement among health professionals caring for...

  • In-house infection screening.  // Nursing Standard;3/21/2012, Vol. 26 Issue 29, p66 

    Team strives to increase uptake of hepatitis C services.

  • Association between hepatitis C virus and oral lichen planus. Alves, Mônica Ghislaine Oliveira; Almeida, Janete Dias; Cabral, Luiz Antonio Guimarães // Hepatitis Monthly;Feb2011, Vol. 11 Issue 2, p132 

    No abstract available.

  • Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels. Grebely, Jason; Oser, Megan; Taylor, Lynn E.; Dore, Gregory J. // Journal of Infectious Diseases;Mar2013, Vol. 207 Issue suppl_1, pS19 

    The majority of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection occurs among persons who inject drugs. Rapid improvements in responses to HCV therapy have been observed, but liver-related morbidity rates remain high, given notoriously low uptake of HCV treatment....

  • Early HCV RNA detection could pay off for healthcare workers.  // PharmacoEconomics & Outcomes News;2/7/2009, Issue 571, p7 

    The article discusses a study on occupational hepatitis C virus (HCV) infection. According to French researchers, for healthcare workers exposed to hepatitis C virus (HCV) infection, a strategy based on early HCV RNA testing is reasonably cost-effective, and is therefore recommended for use in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics